UK competitions watchdog told to cover pharma firms’ costs after investigation failed Regulators The Supreme Court today said the UK’s Competition and Markets Authority (CMA) could be forced to cover Pfizer and Flynn Pharma’s legal costs, following the collapse of its case into the two pharmaceutical firms. The landmark ruling could see UK regulators made liable to pay the costs of those subject to failed investigations, after the [...]
Invidior unveils $100m share repurchase scheme with new drugs powering rebounding revenues BIG PAYOUT Invidior has announced a $100 plan to return capital to shareholders, with the pharmaceutical firm on track to achieve its full-year guidance.
Martin Shkreli’s lawyers ask to drop him as client as ‘pharma bro’ owes $2m in legal fees Pharma Bro Martin Shkreli’s lawyers are seeking to drop him as a client, over claims the price-hiking pharma exec owes them $2.04m (£1.57m). Philadelphia headquartered law firm Duane Morris LLP asked for a judge’s permission to pull out of representing Shkreli after claiming the imprisoned former hedge fund manager “has no assets” to pay its fees. The [...]
Oxford Nanopore Technology has spike in revenue but losses up more than £100m March 22, 2022 A UK-based technology research firm has had spike in revenue by £30m, but an almost £100m loss from 2020. Oxford Nanopore Technologies, which develops state-of-the-art technology to analyse individual molecules, increased its intake to £134m in 2021, up from £114m. The company’s gross profit was up from 41 per cent to almost 55 per cent, [...]
J&J and three other drug distributors settle opioid crisis lawsuits for $26bn February 25, 2022 US pharma giant Johnson & Johnson, and three of America’s largest medical distributors, have agreed to pay $26bn (£19bn) to settle more than 3,000 lawsuits over the role they played in fuelling America’s opioid crisis. New Jersey drugmaker J&J, and medicine distributors Cardinal Health, AmerisourceBergen, and Distributors McKesson, finalized a deal through which they will [...]
AIDS scientists cure human for the first time: Former HIV patient is off medication, asymptomatic and healthy February 16, 2022 Researchers in the U.S. have said they have cured HIV in a human being for the very first time. The scientists said the mixed-race New York woman, who was previously HIV positive, was now “off medication, asymptomatic and healthy”, according to various media reports. The scientists reportedly used a cutting-edge stem cell transplant method that [...]
First patient in UK gets ‘vaccine’ for cancer that should help immune system ward off cancer permanently February 14, 2022 A Merseyside man has become the first in the UK to receive a ‘vaccine’ that is hoped will stop his recurring head and neck cancer from returning, in a clinical research trial which may help bring further ground-breaking treatments for the disease. The clinical research team at The Clatterbridge Cancer Centre has given patient Graham [...]
Informa offloads Pharma Intelligence to Warburg Pincus for £1.9bn as firm shifts focus February 10, 2022 Informa has agreed to sell Pharma Intelligence to US private equity group Warburg Pincus for £1.9bn, as the UK firm looks to boost shareholder value.
UK’s largest ever health research project is looking for 5 million Brits January 23, 2022 A major health study which aims to predict who will get ill in their later years even before they show symptoms needs a record 5m volunteers. Hoped to be the UK’s largest ever health research programme, Our Future Health will track people throughout their lives in a bid to come up with new ways to [...]
France discovers new Covid variant IHU with 46 mutations amid 271,000 coronavirus infections, biggest one-day jump on record January 5, 2022 French media are reporting that a new Covid variant with 46 mutations has been discovered in the country. The new strain, named IHU, has been discovered in the southwest of France and, according to multiple news outlets, intensive care and hospital admissions have been increasing in that region in recent days. So far, there are [...]